论文部分内容阅读
急性淋巴细胞白血病(ALL)治疗的进展,虽使一些病人得到很长的缓解期,但其它病人却很快死于复发,所以预测 ALL 预后的因素已引起重视。区分高度危险的复发病例,对改进治疗有重要意义。141例高白细胞的 ALL(H-ALL)患者(男85,女56),最初白细胞数均>10万/mm~3,幼稚细胞占67～100%(中数94%,平均96%)。治疗分两组:1972年前,有84例用中等量强的松、长春新碱和柔红
Progress in the treatment of acute lymphoblastic leukemia (ALL), although some patients get a long remission, but other patients died of recurrence soon, so predict the prognosis of ALL have attracted the attention of factors. Distinguish between highly dangerous recurrence cases, to improve the treatment of great significance. Of the 141 patients with ALL (H-ALL) with high white blood cell count (85 for males and 56 for females), the initial number of white blood cells was> 100,000 / mm3 and the percentage of naive cells was 67-100% (median 94%, mean 96%). Treatment was divided into two groups: before 1972, 84 cases with moderate amounts of prednisone, vincristine and soft red